On June 23, INOVIO (INO) announced that it received a $71 million contract from the U.S. Department of Defense in order to support large-scale manufacturing of the company’s CELLECTRA® 3PSP device. Both the company’s proprietary CELLECTRA® 3PSP smart device and the CELLECTRA® 2000 deliver INO-4800 directly into the skin. INO-4800 is the company’s COVID-19 vaccine that is currently […]
On June 15, the FDA approved Eli Lilly and Company’s (LLE) new drug, Lyumjev™. It is a new rapid-acting form of insulin designed to speed the absorption of insulin into the blood stream and resduce A1C levels. Lyumjev is a novel formulation of insulin lispro that controls high blood sugar after meals in adults with […]
SuperCom (SPCB) announced on June 4 that the company was awarded a new 5-year contract with the Latvian national government. Latvia’s Ministry of Justice will deploy SuperCom’s PureSecurity Electronic Monitoring (EM) Suite. SuperCom’s technology provides electronic monitoring of offenders using both RF House Arrest and GPS Tracking solutions. Sonal detected the event and issued […]
The May 2020 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide
Cubic Corporation (CUB) announced on June 1 that Cubic Defence U.K. was awarded a $35 million contract. Under the terms of the three-year contract, Cubic will provide support and repair of the British Army’s Area Weapons Effects Simulator (AWES) System at training facilities in the U.K. and Canada. Cubic Defence U.K. is part of the […]
On May 26, argenx (ARGX) reported positive Phase 3 clinical trial results from the ADAPT trial of efgartigimod. The ADAPT trial evaluates improvement in the Myasthenia Gravis Activities of Daily Living (MG-ADL) score for acetylcholine receptor-antibody positive (AChR-Ab+) generalized myasthenia gravis (gMG) patients. Respondents in the trial saw an improvement of at least two points […]
Let us send you a summary of the signals Sonal generates EVERY WEEK… and you can decide if you’re missing anything.